Skip to search formSkip to main contentSkip to account menu

recurrent breast cancer

Known as: Breast Cancer, Recurrent, Recurrent Breast Carcinoma, breast cancer recurrent 
The reemergence of carcinoma in the breast after a period of remission
National Institutes of Health

Related topics

Related topics

13 relations
14-3-3 Protein Zeta/DeltaBreastEpithelial CellsEpithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Sentinel lymph node surgery in locally recurrent breast cancer.
BACKGROUND Patients with locally recurrent breast cancer can also harbor regional nodal disease. Sentinel lymph node (LN; SLN… 
Review
2005
Review
2005
Full-Thickness Chest Wall Resection for Recurrent Breast Carcinoma: An Institutional Review and Meta-analysis
Locoregional recurrence of breast cancer can occur in up to 30 per cent of patients and has often been considered to indicate a… 
2003
2003
Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer
BackgroundDocetaxel has shown remarkable radiosensitizing propertiesin vitro. In this study we investigated whether the addition… 
Review
1998
Review
1998
Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructions.
PURPOSE To determine the mammographic appearance of locally recurrent cancer in patients with breast reconstructions with… 
1994
1994
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
A late phase II clinical study of RP56976 (Docetaxel), a new semisynthetic anticancer agent, was conducted in patients with… 
1992
1992
C-erbB-2 protein in the sera of breast cancer patients
SummaryThe c-erbB-2 protein was measured in sera of patients with breast cancer or benign breast diseases to study the… 
Review
1988
Review
1988
Distant recurrence in breast cancer. Survival expectations and first choice of chemotherapy regimen.
Controversial questions in recurrent breast cancer include the magnitude of the survival benefit of combination chemotherapy and… 
Highly Cited
1982
Highly Cited
1982
A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Abstract We compared antiestrogen therapy (tamoxifen) with an estrogen suppression regimen (aminoglutethimide-hydrocortisone) in… 
1979
1979
Parasternal lymphoscintigraphy: implications for the treatment planning of internal mammary lymph nodes in breast cancer.
Highly Cited
1975
Highly Cited
1975
An effective low‐dose intermittent cyclophosphamide, methotrexate, and 5‐fluorouracil treatment regimen for metastatic breast cancer
A low‐dose, three‐drug regimen, C.M.F. (cyclophosphamide 50 mg, p.o., days 1–14; methotrexate, 25 mg, and 5‐fluorouracil, 500 mg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)